Difference between revisions of "DCE MRI Biomarker Ctte"
Jump to navigation
Jump to search
| (106 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
:Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD | :Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD | ||
| − | : | + | :RSNA Staff Support: Susan Stanfa |
| − | * [ | + | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vRzQYPdYm51Ak3VYii84CtIDFiYRIylH2IkHQZxdAAjJTAVX4iRqlGl2tety1pnDFKN9kLxoKI-RcoM/pubhtml?gid=1048658726&single=true Roster] |
| Line 8: | Line 8: | ||
Develop a quantitative imaging profile for Dynamic Contrast Enhanced MRI. | Develop a quantitative imaging profile for Dynamic Contrast Enhanced MRI. | ||
| − | + | *[[MR Acquisition Protocols]] | |
| + | *[[Synthetic DCE-MRI Data]] | ||
| − | |||
| − | *[[Media: | + | ==DCE MRI Meetings== |
| − | *[[Media: | + | Biweekly Zomm meetings, 2nd and 4th Mondays of each month @ 11am-12pm Central Time (Contact [mailto:qiba@rsna.org qiba@rsna.org] for details) |
| − | *[[Media: | + | |
| + | '''Recently Approved Call Summaries''' | ||
| + | *[[Media:2021_10-25_QIBA_DCE-MRI_BC_Call_Summary-FINAL.pdf|October 25, 2021]] | ||
| + | *[[Media:2021_10-11_QIBA_DCE-MRI_BC_Call_Summary-FINAL.pdf|October 11, 2021]] | ||
| + | *[[Media:2021_09-27_QIBA_DCE-MRI_BC_Call_Summary-FINAL-2.pdf|September 27, 2021]] | ||
'''''[[DCE-MRI BC Call Summaries Archive]]''''' | '''''[[DCE-MRI BC Call Summaries Archive]]''''' | ||
| − | + | <br /> | |
| − | [[QIBA DCE-MRI Technical Committee Call Summaries]] | + | <br /> |
| + | * [[QIBA DCE-MRI Technical Committee Call Summaries|DCE-MRI TC Call Summaries Archive 2008-2012]] | ||
| + | * Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page | ||
==Profile Development== | ==Profile Development== | ||
| Line 29: | Line 35: | ||
*[[Tools and recommendation for structured literature review]] | *[[Tools and recommendation for structured literature review]] | ||
*[[Archived DCE-MRI Profiles]] | *[[Archived DCE-MRI Profiles]] | ||
| + | |||
| + | ==Reference Materials== | ||
| + | |||
| + | *[[Media:Barboriak T1 DRO report 20130903a.pdf|T1 DRO Report -- 20130903 -- Dr Barboriak]] | ||
| + | *[[Media:DWI proposal of DCE-MRI TC 16Nov2011 (2).doc|DWI Proposal for the DCE-MRI Tech Ctte]] ''12.14.2011'' | ||
| + | *[[Media:Synthetic data presentation 20110929 redact.pdf|QIBA DCE-MRI Synthetic Data Presentation -- 20110929--Dr. Barboriak]] | ||
| + | *[[Media:RSNA QIBA May2010 MR Phantom.pdf|MR Phantom Development / Data Efforts - May 2010 QIBA Meeting Breakout Session]] | ||
| + | *[[Media:Prototype Phantom 20100203.pdf|Prototype Phantom - 20100203]] | ||
| + | *[[Media:Q-MRI-Poster1-Jackson-20091118.ppt|QIBA Quantitative MRI Poster for RSNA 2009 Annual Meeting]] | ||
| + | *[[Media:Phantom Study Protocol rev20091028.pdf|DCE-MRI Phantom Study Protocol -- rev20091028]] | ||
| + | *[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson]] | ||
| + | |||
| + | |||
| + | ==QIBA Funded Projects== | ||
| + | |||
| + | ====Round 1==== | ||
| + | *[[VirtualScopics, Inc.]] | ||
| + | **[[Media:DrJackson QIBA Phantom 09203 AMR3.pdf|Example RSNA DCE-MRI Phantom Data Analysis Report]] | ||
| + | |||
| + | *[[Duke University Medical Center]] | ||
| + | *[[The University of Texas M.D. Anderson Cancer Center]] | ||
| + | |||
| + | ====Round 2==== | ||
| + | |||
| + | *[[Media:4-UPenn-Test-Retest.-Yr2.pdf|Test-Retest Evaluation of Repeatability of DCE-MRI and DWI in Human Subjects]] | ||
| + | |||
| + | ====Round 3==== | ||
| + | |||
| + | *[[QIBA Artificial Data Evaluation Software]] | ||
| + | |||
| + | *[[Media:Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis.pdf|Project (J) Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis (Fraunhofer MEVIS, Germany)]] | ||
| + | |||
| + | *[[Media:DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T.pdf | Project (H) DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T (University Hospital Cologne, Germany)]] | ||
| + | |||
| + | ====Round 4==== | ||
| + | |||
| + | *[[Media:Digital Reference Object for DCE-MRI Analysis Software Verification.pdf|Project (AA) Digital Reference Object for DCE-MRI Analysis Software Verification (Cleveland Clinic Foundation)]] | ||
| + | |||
| + | *[[Media:DRO for DCE-MRI Analysis Software Verification.pdf|Project (T) Digital Reference Object for DCE-MRI Analysis Software Verification 2 (Duke University)]] | ||
| + | |||
| + | *[[Media:RSNA DCE-MRI Phantom Automated Analysis Software Package Development.pdf|Project (U) RSNA DCE-MRI Phantom Automated Analysis Software Package Development (University of Wisconsin)]] | ||
| + | |||
| + | ====Round 5==== | ||
| + | *[[Media:Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit.pdf | Project (K) Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit (Duke University)]] | ||
| + | |||
| + | ====Round 6==== | ||
| + | *[[Media:Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI.pdf | Project (Z) Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI (University of Southern California)]] | ||
==Historical Background - Formation of the Group== | ==Historical Background - Formation of the Group== | ||
| − | |||
| − | |||
| − | |||
Revision as of 01:08, 25 November 2021
- Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
Develop a quantitative imaging profile for Dynamic Contrast Enhanced MRI.
DCE MRI Meetings
Biweekly Zomm meetings, 2nd and 4th Mondays of each month @ 11am-12pm Central Time (Contact qiba@rsna.org for details)
Recently Approved Call Summaries
DCE-MRI BC Call Summaries Archive
- DCE-MRI TC Call Summaries Archive 2008-2012
- Earlier materials can be found on the PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee page
Profile Development
- DCE-MRI Profile, Section IV Compliance-AG v1.7 05-21-2014
- DCE-MRI Profile, Section IV Compliance-AG 01-22-2014
- DCE-MRI Quantification Profile v1.6 2011-12-13 (Public comment closed Feb 2012)
- DCE-MRI Profile Supporting Literature Review Revised 05.02.2011
Reference Materials
- T1 DRO Report -- 20130903 -- Dr Barboriak
- DWI Proposal for the DCE-MRI Tech Ctte 12.14.2011
- QIBA DCE-MRI Synthetic Data Presentation -- 20110929--Dr. Barboriak
- MR Phantom Development / Data Efforts - May 2010 QIBA Meeting Breakout Session
- Prototype Phantom - 20100203
- QIBA Quantitative MRI Poster for RSNA 2009 Annual Meeting
- DCE-MRI Phantom Study Protocol -- rev20091028
- Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson